Introducing the LifeSci NYC Internship Program
The growth of New York City's life sciences industry depends on attracting and retaining a steady stream of qualified talent to start companies and fill essential roles, especially as New York City's $500 million investment is projected to create 16,000 high-paying jobs in the industry.
From Our Partners
The Silverstein Foundation, REGENXBIO, and OrbiMed Launch Prevail Therapeutics
The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. (“REGENXBIO”), and OrbiMed today announced the formation and launch of Prevail Therapeutics, Inc., (“Prevail”), a new company focused on discovering and developing novel biologic therapies for Parkinson’s Disease and other neurodegenerative diseases.
From the Community